Global Health Ltd

Global Health Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Global Health Ltd

₹ 1,270 -0.43%
03 Jul 10:57 a.m.
medanta.org BSE: 543654 NSE: MEDANTA
About

Global Health Limited is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India. The company has key specialties in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology.[1]

Key Points

** Hospital Count**[1] Global Health has 5 hospitals in operation (Gurugram, Indore, Ranchi, Lucknow, and Patna), and 1 hospital under construction (Noida) under the ‘’Medanta’’ Brand.
Company provides healthcare services in 30+ medical specialties and engages 1,300+ doctors, spanning an area of 4.7 msf.
Operational hospitals have 2,467 installed beds.
They also operate 6 multi-specialty clinics at DLF Cybercity Gurugram, Delhi Airport, south Delhi, Darbhanga, Patna, and Subhash Chowk Gurugram.[2]

Website BSE NSE
  • Market Cap ₹ 34,095 Cr.
  • Current Price ₹ 1,270
  • High / Low ₹ 1,514 / 615
  • Stock P/E 94.5
  • Book Value ₹ 106
  • Dividend Yield 0.00 %
  • ROCE 17.4 %
  • ROE 13.5 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 41.8% CAGR over last 5 years

Cons

  • Stock is trading at 12.0 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 13.2% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
467 411 473 494 490 506 545 580 565 579
356 344 372 391 394 400 435 452 439 456
Operating Profit 111 67 101 103 95 106 109 128 126 122
OPM % 24% 16% 21% 21% 19% 21% 20% 22% 22% 21%
8 12 8 13 13 25 33 26 23 33
Interest 7 6 7 7 6 6 6 6 6 6
Depreciation 22 22 22 22 22 20 20 22 22 23
Profit before tax 90 51 80 87 80 104 116 127 121 125
Tax % 24% 25% 27% 25% 26% 22% 26% 25% 28% 26%
68 38 58 65 59 81 86 95 87 92
EPS in Rs 2.69 1.50 2.30 2.58 2.19 3.02 3.21 3.54 3.25 3.44
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
1,277 1,343 1,441 1,472 1,227 1,765 1,959 2,280
1,158 1,218 1,297 1,253 1,054 1,384 1,551 1,783
Operating Profit 119 125 144 219 173 381 409 497
OPM % 9% 9% 10% 15% 14% 22% 21% 22%
67 49 64 43 28 35 61 103
Interest 19 24 21 33 29 33 32 24
Depreciation 77 86 91 99 88 87 86 87
Profit before tax 89 64 97 131 84 296 352 489
Tax % 39% 42% 35% 22% 32% 26% 25% 26%
54 37 63 103 57 219 263 361
EPS in Rs 11.21 7.70 12.81 20.82 11.55 8.64 9.82 13.44
Dividend Payout % -0% -0% -0% -0% -0% -0% -0% -0%
Compounded Sales Growth
10 Years: %
5 Years: 10%
3 Years: 23%
TTM: 16%
Compounded Profit Growth
10 Years: %
5 Years: 42%
3 Years: 85%
TTM: 37%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 87%
Return on Equity
10 Years: %
5 Years: 11%
3 Years: 13%
Last Year: 14%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 48 81 49 49 50 51 54 54
Reserves 1,070 1,141 1,230 1,341 1,434 1,689 2,435 2,795
Preference Capital 32 -0 32 32 -0 -0 -0
183 168 136 19 228 308 288 260
335 318 343 549 291 314 402 414
Total Liabilities 1,637 1,709 1,758 1,958 2,002 2,361 3,179 3,523
966 1,162 869 929 851 827 810 842
CWIP 8 7 5 3 4 6 75 183
Investments 21 -0 356 500 626 734 765 790
642 540 528 525 521 794 1,529 1,708
Total Assets 1,637 1,709 1,758 1,958 2,002 2,361 3,179 3,523

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
124 152 193 201 235 431 341
-112 -104 -45 -250 -313 -257 -699
-6 -49 -56 -37 98 404 -66
Net Cash Flow 6 -1 92 -86 20 577 -424

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 31 41 42 37 39 36 32 31
Inventory Days 36 26 26 37 39 33 33 29
Days Payable 132 124 142 135 134 84 112 92
Cash Conversion Cycle -66 -56 -74 -61 -56 -16 -46 -32
Working Capital Days -23 -4 -7 -11 -10 8 -13 -1
ROCE % 6% 8% 11% 7% 17% 16%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
33.08% 33.08% 33.07% 33.06% 33.05% 33.04%
9.36% 9.89% 10.58% 10.69% 11.36% 12.10%
12.55% 12.34% 10.79% 10.93% 11.15% 10.25%
45.01% 44.67% 45.55% 45.31% 44.45% 44.60%
No. of Shareholders 1,21,4071,07,1201,09,7981,16,6271,24,7751,66,253

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls